CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 84 enrolled
Drug / intervention
Global Fibroid Ablation (GFA) +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01563783
NCT01563783N/ACompleted

The Trust (Treatment Results of Uterine Sparing Technologies) Study

Acessa Health, Inc.·interventional·Posted Mar 27, 2012·Updated Feb 1, 2023

In Brief

A clinical study evaluating Global Fibroid Ablation (GFA), Abdominal or Laparoscopic Myomectomy, and 1 other intervention for Uterine Fibroids. Completed, enrolled 84 participants across 1 site.

Detailed Summary

This Post Market study is being conducted to compare the direct and indirect cost of three approaches (GFA, myomectomy, and uterine artery embolization) for the treatment of symptomatic uterine fibroids.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 27, 2012
Enrollment StartDec 1, 2012
Primary CompletionSep 1, 2017
Study CompletionJun 1, 2022
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 14.3 years ago

Interventions

Global Fibroid Ablation (GFA)procedure

GFA is being used for the treatment of symptomatic uterine fibroids

Abdominal or Laparoscopic Myomectomyprocedure

Myomectomy is a procedure in which uterine fibroids are surgically removed from the uterus.

Uterine Artery Embolization (UAE)procedure

UAE is a minimally invasive surgical procedure used to treat uterine fibroids.